Applying a drug topically means placing it directly on the skin or a mucous membrane so it can act locally at the site, rather than traveling through the digestive system or bloodstream first. This approach has been used for centuries, from plant poultices to modern prescription patches, and it remains one of the most common ways people encounter medications in everyday life. But the science behind what happens after you rub something onto your skin is more nuanced than most people realize, because the skin is not a passive wrapper. It is an active barrier, and how much of any substance actually reaches its target depends on a surprisingly long list of factors.
What “Topical” Actually Covers
The word gets used loosely, but in pharmacology, topical application splits into two distinct categories depending on where the drug is meant to end up. Products designed for a local effect aim to treat the skin itself or the tissue just beneath it: think hydrocortisone cream for a rash, or a lidocaine patch for a sore shoulder. Products designed for a systemic effect, by contrast, use the skin as an entry point to the bloodstream so the drug can reach organs elsewhere in the body, such as a nicotine patch or a fentanyl patch. The technical term for this second category is transdermal delivery, and it works because blood vessels in the tissue beneath the outer skin layer can pick up absorbed molecules and carry them throughout the body.1PubMed Central. Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies
The distinction matters practically. When you apply a topical anti-inflammatory gel to a swollen knee, you want the drug concentrated in the joint tissues and not flooding your whole system. When you wear a hormonal patch, you want the opposite: steady absorption into the blood. The formulation, the drug’s chemistry, and the location on the body are all tuned differently depending on which goal the product serves.2PubMed Central. Transdermal and Topical Drug Administration in the Treatment of Pain
The Skin Barrier and How Drugs Get Past It
The outermost layer of your skin, the stratum corneum, is the main obstacle standing between a topical product and the tissue it needs to reach. This layer is essentially a wall of dead, flattened skin cells cemented together by waxy lipids. It evolved specifically to keep things out: water, microbes, chemicals. Any drug applied to the surface has to find a way through or around this barrier.
There are two primary routes. Fat-soluble molecules tend to slip between the cells, weaving through the lipid layers that hold the stratum corneum together. Water-soluble molecules take a different path, passing through the cells themselves and the protein structures connecting them.3PubMed Central. Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles A third route exists through hair follicles and sweat glands, which punch through the stratum corneum and offer a shortcut, especially for larger molecules or nanoparticles that would otherwise be stopped cold. Research has shown that skin permeation depends on both follicular and non-follicular pathways rather than just one or the other.
A widely cited guideline in dermatology holds that molecules need to weigh less than about 500 daltons to pass through the stratum corneum effectively. Virtually all common topical drugs and contact allergens fall below this threshold. Larger molecules generally cannot penetrate in meaningful amounts, which is why things like collagen in a face cream do not actually reach the deeper layers of your skin in intact form.4PubMed. The 500 Dalton rule for the skin penetration of chemical compounds and drugs
Why the Same Drug Works Better in Some Spots Than Others
Your body is not uniformly absorptive. The stratum corneum varies in thickness depending on where you look, and absorption rates can differ dramatically from one region to another. In general, the head, neck, and genital area absorb chemicals far more readily than the trunk, back, or thighs.5PubMed. Effects of anatomical location on in vivo percutaneous penetration in man
A systematic review of human skin studies confirmed that the scalp and scrotum are particularly permeable compared to the abdomen. The likely reason is the density of hair follicles in those areas, which create more of those shortcut pathways through the barrier.6PubMed. Regional variation in percutaneous absorption in in vitro human models: a systematic review This has real consequences. A potent steroid cream that is safe to use on thick-skinned areas like the palms or soles can cause thinning and other side effects when used on the face or groin, where much more drug gets through. Dermatologists often prescribe different strengths of the same medication depending on where on the body you need to apply it.
Skin condition also changes the equation. Damaged or inflamed skin absorbs more. One study found that irritated skin allowed roughly three times as much of the antibiotic metronidazole to penetrate compared to intact skin.7PubMed. The effect of irritant dermatitis on cutaneous bioavailability of a metronidazole formulation, investigated by microdialysis and dermatopharmacokinetic method This is worth keeping in mind: the conditions you are treating, like eczema or psoriasis, may simultaneously increase how much drug your skin absorbs, which can be both helpful (the drug reaches the problem area) and risky (more drug enters the bloodstream than expected).
Age and Skin Maturity
Babies and older adults are not just small or wrinkled versions of the average adult when it comes to skin absorption. Neonatal and infant skin is thinner, more permeable, and structurally less developed, making it more vulnerable to irritants and more absorptive of anything applied to it.8PubMed Central. Skin Barrier Function in Neonates and Infants This is why pediatricians are cautious about topical medications in newborns. Even products considered safe for adult skin can deliver disproportionately high doses through infant skin, especially when applied over large surface areas relative to body weight.
In older adults, the picture is different but still important. Aging skin tends to be drier and thinner, and the lipid composition of the stratum corneum changes. These shifts can alter how effectively topical drugs penetrate, sometimes increasing absorption in areas where skin has become fragile and sometimes decreasing it where the skin has become less hydrated. Moisturizing the skin before applying a medication can affect how much drug gets through, which is one reason why dermatologists sometimes give specific instructions about whether to apply a moisturizer before or after a medicated product.
The Vehicle Matters as Much as the Drug
When people think about a topical medication, they tend to focus on the active ingredient. But the stuff the active ingredient is mixed into, the vehicle, plays an enormous role in how well the product works. Ointments, creams, gels, and lotions are not interchangeable packaging. Each has a different composition that influences how the drug interacts with the skin.9PubMed Central. Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
Ointments are greasy and occlusive, meaning they form a barrier on the skin surface that traps moisture and pushes the drug into contact with the stratum corneum for longer. They tend to deliver drugs more effectively than lighter formulations, especially for thick, dry plaques of psoriasis or eczema. Creams are emulsions of oil and water that absorb more cleanly and feel less sticky, making patients more willing to use them regularly, even if they may deliver slightly less drug per application. Gels are mostly water-based or alcohol-based and work well on hairy areas like the scalp because they do not mat down hair. Lotions are the thinnest and spread most easily over large areas but evaporate quickly, leaving less time for absorption.
Hydrogel-based formulations have received attention for their ability to hydrate the skin aggressively, which loosens the stratum corneum and improves drug penetration. Research comparing hydrogel-based creams to conventional creams showed that the hydrogel versions delivered roughly double the amount of a lipophilic probe molecule and nearly triple the amount of a hydrophilic one into the skin over the same time period.10Biological and Pharmaceutical Bulletin. Hydrogel-Based Ultra-moisturizing Cream Formulation for Skin Hydration and Enhanced Dermal Drug Delivery The vehicle is not just a carrier; it is part of the treatment.
Chemical Penetration Enhancers
Sometimes the drug and the vehicle alone are not enough. Many topical and transdermal products contain chemical penetration enhancers: substances that temporarily disrupt the skin barrier to let the active ingredient through more efficiently. Common examples include certain alcohols, fatty acids, and surfactants. Despite their chemical diversity, these enhancers work through broadly similar mechanisms. Infrared spectroscopy studies have shown that they either extract lipids from the stratum corneum’s bilayers or make those lipids more fluid, loosening the mortar between the brick-like cells.11PubMed Central. Design principles of chemical penetration enhancers for transdermal drug delivery
The tradeoff is irritation. Any substance potent enough to disrupt the skin barrier is also capable of causing redness, stinging, or dryness if the formulation is not carefully balanced. Product developers spend considerable effort finding enhancers that improve drug delivery without making the product uncomfortable to wear. This is part of why a generic version of a topical drug can feel or perform differently from the brand-name original, even when they contain the same active ingredient at the same concentration: the inactive ingredients, including enhancers, may differ.
Steroid Fears and the Reality of Topical Safety
No class of topical drug provokes more anxiety than corticosteroids. “Steroid phobia” is well-documented among patients prescribed topical steroids for eczema or psoriasis, with many people applying less than directed or stopping early because they fear side effects like skin thinning or systemic hormonal disruption. Some of those concerns are grounded in real biology, but the magnitude of risk is frequently overestimated.
A systematic review looking at topical steroids in plaque psoriasis found that skin thinning, assessed clinically, occurred in zero to five percent of patients across studies lasting from four weeks to a year. The same review evaluated whether topical steroids suppressed the body’s natural cortisol production, a systemic side effect that worries many patients. Even when treating the scalp, a highly absorptive area, or patients with extensive disease, the gold-standard test for adrenal function came back normal. There was no evidence of clinically significant hormonal suppression.12PubMed. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy
A separate analysis of clinical trials found that only one out of sixteen trials reported pathological adrenal suppression, and it involved patients using double the maximum recommended dose of the strongest available steroid continuously for up to 18 months. Some patients did show temporary dips in cortisol early in treatment, but in about half of them, cortisol levels returned to normal on their own even with continued therapy.13PubMed. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression The upshot is that topical steroids used as directed, at appropriate potency for the body site, are safer than many patients believe. Undertreating a skin condition out of steroid fear can cause more harm than the medication itself.
Physical Delivery Technologies
For drugs that are too large or too charged to cross the skin barrier passively, researchers have developed physical methods to push them through. Two of the most studied approaches are microneedles and iontophoresis, and combining the two appears to be especially promising.
Microneedles are arrays of tiny needles, typically shorter than a millimeter, that painlessly puncture the stratum corneum and create microchannels for drug delivery. They are too short to reach nerve endings, so patients generally do not feel them. Iontophoresis uses a mild electrical current to drive charged drug molecules through the skin. Each technology improves absorption on its own, but research has shown that using them together can push through molecules that neither could deliver alone. In one study, microneedle pretreatment followed by iontophoresis significantly increased the skin permeation of large molecules compared to either method used in isolation.14PubMed. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis The combination can also give precise electronic control over the rate of delivery, which is valuable for drugs where dosing needs to be carefully managed.15PubMed. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery
More recent work has integrated these approaches into smart platforms that respond to biological signals. One example is a microneedle patch designed for insulin delivery that uses iontophoresis to push insulin deeper while maintaining sensitivity to blood glucose levels, so the release adjusts in real time.16ACS Applied Materials & Interfaces. Iontophoresis-Integrated Smart Microneedle Delivery Platform for Efficient Transdermal Delivery and On-Demand Insulin Release These technologies are largely still in development or early clinical stages, but they point toward a future where the skin could be a practical delivery route for drugs currently limited to injections.
Nanoparticle and Lipid-Based Carriers
Another frontier in topical delivery involves packaging drugs inside nanoparticles so small they can navigate through or around the skin barrier. Solid lipid nanoparticles, for example, have been shown to create a localizing effect in the upper skin layers. One study found that a drug incorporated into lipid nanoparticles concentrated in the epidermis at six hours after application, providing targeted delivery to the disease site while limiting how much escaped into the bloodstream.17PubMed. Drug targeting by solid lipid nanoparticles for dermal use This kind of epidermal targeting could improve the benefit-to-risk ratio of topical therapy by keeping the drug where it is needed and out of places where it causes side effects.
Chitosan-based nanoparticles are another example, particularly for mucosal surfaces like the eyes, nose, or mouth, where they can extend the time a drug stays in contact with the tissue and even temporarily open the junctions between cells to improve absorption. These nanocarrier systems are not yet mainstream in consumer products, but they are moving through clinical development for conditions ranging from skin infections to inflammatory diseases.
Occupational Skin Exposure
Topical absorption is not only a pharmaceutical concern. Workers across many industries are routinely exposed to chemicals through their skin, and dermal absorption can contribute significantly to their overall chemical dose. In some cases, skin contact accounts for a larger share of exposure than inhalation.18PubMed Central. Potential health effects associated with dermal exposure to occupational chemicals
Occupational health agencies use “skin notation” designations to flag chemicals whose dermal absorption is high enough to meaningfully raise a worker’s internal dose beyond what they would get from breathing workplace air alone. One set of criteria defines significant dermal absorption as that which raises the body’s internal dose of a nonvolatile chemical by at least 30 percent above what inhalation alone would produce.19PubMed. Dermal absorption potential of industrial chemicals: criteria for skin notation For volatile chemicals, the threshold is set even higher. These designations matter for protective equipment decisions and biological monitoring. If you work with solvents, pesticides, or certain industrial compounds and your employer provides gloves or barrier creams, those measures are there because the skin is a real route of entry, not a hypothetical one.
How Researchers Test Topical Products
Regulators need to know that a topical product actually delivers its drug to the right place in the right amount. Since you cannot easily measure drug concentration inside living skin the way you can draw blood for a systemic drug, testing topical products requires specialized methods. The most widely used lab tool is the Franz diffusion cell, which places a skin sample between a donor chamber (where the product goes) and a receptor chamber (where researchers measure how much drug comes through over time).
A complementary technique called confocal Raman spectroscopy can measure drug concentration at different depths within the skin itself, without cutting or destroying the sample. Recent work comparing these two methods found an excellent correlation between how much drug permeated through skin in the Franz cell and how much appeared at a specific depth in living skin measured by Raman spectroscopy, suggesting that the lab test is a reliable stand-in for what happens in a real person. This kind of in vitro-to-in vivo correlation is important for ensuring that generic topical products perform the same as brand-name originals.
Skin Differences Across Species
Anyone who has applied flea medication to a dog’s neck or a pour-on dewormer to a cow’s back has encountered topical drug delivery in veterinary medicine. But animal skin is not human skin. Evolution has produced highly specialized barriers across species, with anatomical structure and permeability that differ considerably between animals and humans.20PubMed. Veterinary drug delivery: potential for skin penetration enhancement Fur density, skin thickness, lipid composition, and follicle structure all vary. A formulation designed for cattle will not necessarily work on a horse, much less on a person. This is one reason researchers cannot simply apply findings from animal skin studies to human drug development without careful translation, and it is why regulatory agencies generally require human skin data before approving a topical product for people.
Even within laboratory research, the choice of animal model matters. Hairless mouse skin is commonly used in permeation studies because it removes the variable of dense fur, but mouse skin is thinner and more permeable than human skin, so results from these studies tend to overestimate how much drug would penetrate in a human. Pig skin, on the other hand, is structurally closer to human skin and is often considered a better model. These practical considerations shape how researchers design experiments and how cautiously they interpret results before moving to human trials.